Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07XKG
|
|||
| Former ID |
DNC011129
|
|||
| Drug Name |
2-(4-phenylbutyl)pyrido[2,3-d]pyrimidin-4(3H)-one
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H17N3O
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CCCCC2=NC3=C(C=CC=N3)C(=O)N2
|
|||
| InChI |
1S/C17H17N3O/c21-17-14-10-6-12-18-16(14)19-15(20-17)11-5-4-9-13-7-2-1-3-8-13/h1-3,6-8,10,12H,4-5,9,11H2,(H,18,19,20,21)
|
|||
| InChIKey |
KGCFTSWBCFAQQI-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Nicotinic acid receptor (HCAR2) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activity. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5426-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.